Series: The Andelot Series on Current Science Controversies

Battling Drug-Resistant Superbugs
Can We Win?

February 5th, 2014 Part of: .

This Forum event will examine the public health menace posed by antimicrobial resistance and the steps to be undertaken to fight the “superbugs.”

Thwarting Killer Mosquitoes
The State-of-the-Art Fight Against Malaria and West Nile Virus

May 1st, 2013 Part of: .

This Forum event focused on the fight against malaria and West Nile virus, emphasizing the latest technologies in mosquito control, challenges in drug resistance, and critical need to sustain efforts — even after incidence declines.

Trust in Vaccines
Why It Matters

November 2nd, 2012 Part of: .

Long a cost-effective stalwart in the public health armament, vaccines have become a target for misinformation that has undermined immunization efforts in parts of the U.S., U.K. and elsewhere, contributing to dangerous and potentially lethal disease outbreaks of measles, polio and more. At the same time, in this “Decade of Vaccines,” steps have been taken Read More…

Bird Flu Research
Dangerous Information on a Deadly Virus

February 15th, 2012 Part of: .

Amid controversy, a cadre of experts are expected to meet in February at the World Health Organization to debate the publication of experiments that made a deadly form of bird flu more contagious in mammals in an effort to understand mechanisms of its evolution. Worries that the data and research could lead to a blueprint Read More…

Smog or Jobs?
The Impact of Tighter Ozone Pollution Control on Health and the U.S. Economy

September 21st, 2011 Part of: .

With a weak U.S. economy shadowing his presidency, Barack Obama has announced his request that the Environmental Protection Agency (EPA) withdraw draft air quality standards that would have tightened ozone pollution controls. President Obama cited “the importance of reducing regulatory burdens and regulatory uncertainty” as the economy recovers. Public health experts and environmental advocates howled Read More…

Alzheimer’s: What is the Value of Knowing Early?
A View Across Five Countries

July 22nd, 2011 Part of: .

Alzheimer’s disease, the most common form of dementia, affects millions of people around the world. This Forum event examined the results of a new poll conducted by the Harvard School of Public Health and Alzheimer Europe on perception and awareness of the disease among residents in the U.S., Germany, France, Spain and Poland – and their views Read More…

Boosting Vitamin D
Not enough or too much?

March 29th, 2011 Part of: .

A long-awaited report from the Institute of Medicine (IOM), “Dietary Reference Intakes for Calcium and Vitamin D,” calls for increasing daily vitamin D intake. Yet some experts say these new recommendations are still too low in vitamin D. Why do these nutrition specialists disagree? This Forum webcast examined the question, “Boosting Vitamin D: Not enough or too Read More…

Mammograms
Who in the World are They Good For?

March 8th, 2011 Part of: .

Controversial new evidence suggests that mammography screening for women in high-income nations may have diminishing value in light of effective modern treatment options. But for women in lower-income nations, mammography screening is not enough of a priority, treatment is poor and women face greater risk. On March 8, 2011, International Women’s Day, expert participants met at The Read More…